Last updated: June 5, 2025
Sponsor: University of Chicago
Overall Status: Active - Recruiting
Phase
N/A
Condition
Rosacea
Scalp Disorders
Acne Inversa
Treatment
N/AClinical Study ID
NCT05710393
IRB18-1861
Ages > 7 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants (affected) with Hidradenitis Suppurativa and related symptoms
Family (unaffected) of participants with Hidradenitis Suppurativa
Exclusion
Exclusion Criteria:
- Children under 7-years of age
Study Design
Total Participants: 500
Study Start date:
September 17, 2019
Estimated Completion Date:
December 01, 2027
Study Description
Connect with a study center
University of Chicago Medicine
Chicago, Illinois 60637
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.